Johnson & Johnson Financial Ratios
JNJ / Health Care|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- Strong profit margin: 27.3%
- Strong return on equity: 31.7%
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
32.9%
ROE ranks in the above average among Health Care companies
Profit Margin
28.5%
Net Income / Revenue
Asset Turnover
0.47
Revenue / Total Assets
Equity Multiplier
2.44
Total Assets / Equity
Composite: 32.9% (reported: 32.9%)
Profitability
Liquidity
Current Ratio
1.03
Quick Ratio
0.77
Solvency
Interest Coverage
-
Efficiency
Asset Turnover
0.47
Inventory Turnover
2.13
Days Sales Outstanding
67 days
As of FY2025 · SEC 10-K · Updated Mar 11, 2026
Earnings Quality
Accrual Ratio
+1.2%
+6.9pp YoY
Earnings are roughly in line with operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.